Literature DB >> 30380424

Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD+ Synthesis.

Laura Palzer1, Jessica J Bader2, Frances Angel1, Megan Witzel1, Sydney Blaser1, Alexis McNeil1, Miles K Wandersee1, N Adrian Leu3, Christopher J Lengner3, Clara E Cho4, Kevin D Welch5, James B Kirkland6, Ralph G Meyer2, Mirella L Meyer-Ficca7.   

Abstract

NAD+ is essential for redox reactions in energy metabolism and necessary for DNA repair and epigenetic modification. Humans require sufficient amounts of dietary niacin (nicotinic acid, nicotinamide, and nicotinamide riboside) for adequate NAD+ synthesis. In contrast, mice easily generate sufficient NAD+ solely from tryptophan through the kynurenine pathway. We show that transgenic mice with inducible expression of human alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase (ACMSD) become niacin dependent similar to humans when ACMSD expression is high. On niacin-free diets, these acquired niacin dependency (ANDY) mice developed reversible, mild-to-severe NAD+ deficiency, depending on the nutrient composition of the diet. NAD deficiency in mice contributed to behavioral and health changes that are reminiscent of human niacin deficiency. This study shows that ACMSD is a key regulator of mammalian dietary niacin requirements and NAD+ metabolism and that the ANDY mouse represents a versatile platform for investigating pathologies linked to low NAD+ levels in aging and neurodegenerative diseases.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACMSD; NAD; NADP; kynurenine; metabolism; niacin; nicotinamide; nicotinic acid; tryptophan; vitamin B3

Mesh:

Substances:

Year:  2018        PMID: 30380424     DOI: 10.1016/j.celrep.2018.09.091

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  15 in total

1.  ACMSD: A Novel Target for Modulating NAD+ Homeostasis.

Authors:  Jun Yoshino
Journal:  Trends Endocrinol Metab       Date:  2019-02-21       Impact factor: 12.015

2.  Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan.

Authors:  Daniel Tzu-Li Chen; Szu-Wei Cheng; Tiffany Chen; Jane Pei-Chen Chang; Bing-Fang Hwang; Hen-Hong Chang; Eric Y Chuang; Che-Hong Chen; Kuan-Pin Su
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

3.  NAMPT Inhibition Induces Neuroblastoma Cell Death and Blocks Tumor Growth.

Authors:  Frederic A Vallejo; Anthony Sanchez; Branko Cuglievan; Winston M Walters; Guillermo De Angulo; Steven Vanni; Regina M Graham
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

4.  Integrated metabolism and epigenetic modifications in the macrophages of mice in responses to cold stress.

Authors:  Jingjing Lu; Shoupeng Fu; Jie Dai; Jianwen Hu; Shize Li; Hong Ji; Zhiquan Wang; Jiahong Yu; Jiming Bao; Bin Xu; Jingru Guo; Huanmin Yang
Journal:  J Zhejiang Univ Sci B       Date:  2022-06-15       Impact factor: 5.552

Review 5.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

6.  Diflunisal Derivatives as Modulators of ACMS Decarboxylase Targeting the Tryptophan-Kynurenine Pathway.

Authors:  Yu Yang; Timothy Borel; Francisco de Azambuja; David Johnson; Jacob P Sorrentino; Chinedum Udokwu; Ian Davis; Aimin Liu; Ryan A Altman
Journal:  J Med Chem       Date:  2020-12-28       Impact factor: 7.446

Review 7.  Advances in NAD-Lowering Agents for Cancer Treatment.

Authors:  Moustafa S Ghanem; Fiammetta Monacelli; Alessio Nencioni
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

Review 8.  Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer.

Authors:  Renata Novak Kujundžić; Marin Prpić; Nikola Đaković; Nina Dabelić; Marko Tomljanović; Anamarija Mojzeš; Ana Fröbe; Koraljka Gall Trošelj
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 9.  NAD+ homeostasis in human health and disease.

Authors:  Rubén Zapata-Pérez; Ronald J A Wanders; Clara D M van Karnebeek; Riekelt H Houtkooper
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

10.  Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD+/NADH ratio.

Authors:  Rolf K Berge; Daniel Cacabelos; Rosa Señarís; Jan Erik Nordrehaug; Ottar Nygård; Jon Skorve; Bodil Bjørndal
Journal:  Lipids Health Dis       Date:  2020-05-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.